4
Changes in Ownership
Veradermics, Inc Filed Acc 0001628280-26-060491
Chief R&D Officer acquired 9,650 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hollander David · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-01 | Grant or award : show line 1 in the form | +9,650 | 9,650 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +19,300 | 19,300 | D |
Loading xslF345X06/wk-form4_1788467701.xml…